Dianthus Therapeutics Ownership | Who Owns Dianthus Therapeutics?
Dianthus Therapeutics Ownership Summary
Dianthus Therapeutics is owned by 137.55% institutional investors, 0.12% insiders. Fmr is the largest institutional shareholder, holding 15.26% of DNTH shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.02% of its assets in Dianthus Therapeutics shares.
DNTH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Dianthus Therapeutics | 137.55% | 0.12% | -37.67% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 8.55M | 15.26% | $753.07M |
| T. rowe price investment management | 3.89M | 8.10% | $379.05M |
| Blackrock funding, inc. /de | 4.39M | 7.83% | $386.50M |
| Wellington management group llp | 3.23M | 6.72% | $314.85M |
| Vanguard group | 2.05M | 5.42% | $84.42M |
| Fairmount funds management | 2.54M | 5.28% | $247.33M |
| Price t rowe associates inc /md/ | 2.51M | 5.24% | $245.16M |
| State street | 2.53M | 4.52% | $223.15M |
| Avidity partners management lp | 2.10M | 4.38% | $205.12M |
| Vanguard capital management | 2.43M | 4.33% | $213.79M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Avidity partners management lp | 2.10M | 32.85% | $205.12M |
| Fairmount funds management | 2.54M | 16.35% | $247.33M |
| Octagon capital advisors lp | 1.84M | 16.14% | $179.53M |
| 5am venture management | 365.05K | 5.26% | $14.36M |
| Spruce street capital lp | 354.82K | 4.97% | $31.24M |
| Tcg crossover management | 1.68M | 3.93% | $163.44M |
| Cormorant asset management, lp | 750.00K | 3.75% | $73.11M |
| Vr adviser | 1.18M | 3.49% | $115.03M |
| Stempoint capital lp | 200.85K | 3.37% | $19.58M |
| Logos global management lp | 800.00K | 3.36% | $77.98M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 3.89M | 0.25% | 2.60M |
| Price t rowe associates inc /md/ | 2.51M | 0.02% | 1.37M |
| Vanguard portfolio management | 1.54M | 0.01% | 974.35K |
| Wellington management group llp | 3.23M | 0.05% | 634.10K |
| Assenagon asset management | 732.25K | 0.06% | 451.60K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -2.61M |
| Deep track capital, lp | - | - | -2.23M |
| Vestal point capital, lp | 1.18M | 2.10% | -2.02M |
| Farallon capital management | - | - | -836.00K |
| Point72 asset management | - | - | -643.60K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 346.00K | 1.37% | 346.00K | $13.62M |
| Caption management | 138.56K | 0.04% | 138.56K | $5.45M |
| Orbimed advisors | 115.00K | 0.21% | 115.00K | $11.21M |
| Quadrature capital | 80.40K | 0.04% | 80.40K | $7.08M |
| Mercer global advisors inc /adv | 65.68K | 0.01% | 65.68K | $6.40M |
Sold Out
| Holder | Change |
|---|---|
| Brooklyn fi | -2.00 |
| Massmutual trust co fsb/adv | -4.00 |
| Montag a & associates | -9.00 |
| Creative financial designs inc /adv | -10.00 |
| Ameritas advisory services | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 275 | 10.00% | 66,067,947 | 6.22% | 137 | 0.51% | 182 | 2.25% | 66 | 15.79% |
| Mar 31, 2026 | 77 | -54.44% | 6,290,279 | -87.19% | 16 | 0.10% | 62 | -48.33% | 14 | -51.72% |
| Dec 31, 2025 | 22 | -85.23% | 2,846,620 | -93.92% | 7 | 0.04% | 15 | -84.38% | 6 | -82.35% |
| Sep 30, 2025 | 34 | -67.31% | 2,900,005 | -92.58% | 8 | 0.07% | 22 | -54.17% | 7 | -82.05% |
| Jun 30, 2025 | 104 | 1.96% | 39,106,737 | 3.69% | 109 | 0.90% | 48 | - | 39 | 34.48% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.20M | 4.02% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.70M | 3.05% | 51.24K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.65M | 3.02% | 77.78K |
| Vanguard Total Stock Mkt Idx Inv | 1.65M | 3.02% | 77.78K |
| Fidelity Growth Company Fund | 1.59M | 2.85% | - |
| Vanguard Health Care Inv | 1.50M | 2.69% | - |
| State Street® SPDR® S&P® Biotech ETF | 1.48M | 2.63% | 38.62K |
| T. Rowe Price Capital Appreciation | 1.29M | 2.31% | -231.10K |
| T. Rowe Price Small-Cap Stock | 1.22M | 2.18% | -7.00K |
| T. Rowe Price US Small-Cap Core Equity | 1.17M | 2.15% | 675.11K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 09, 2026 | Savitz Ryan | EVP, CFO & CBO | Sell | $154.23K |
| Nov 09, 2026 | Savitz Ryan | EVP, CFO & CBO | Sell | $3.38M |
| Nov 09, 2026 | Savitz Ryan | EVP, CFO & CBO | Sell | $25.55K |
| Nov 09, 2026 | Savitz Ryan | EVP, CFO & CBO | Sell | $60.69K |
| Nov 09, 2026 | Savitz Ryan | EVP, CFO & CBO | Sell | $5.31M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 9 |
| 2026 Q3 | - | 33 |
| 2026 Q2 | - | 7 |
| 2026 Q1 | - | 21 |
| 2025 Q4 | - | 5 |
DNTH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools